BCC Flashcards

You may prefer our related Brainscape-certified flashcards:
1
Q

What is basal cell carcinoma?

A

Basal cell carcinomas (BCCs) are slow growing, locally invasive malignant epidermal skin tumours which are thought to arise from hair follicles.

The tumour infiltrates local tissues through the slow irregular growth of subclinical finger-like outgrowths and morbidity results from local tissue invasion and destruction, especially on areas of chronic sun exposure, such as the face, head and neck

Metastasis is relatively rare with a metastasis rate of 0.0028% to 0.5%.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Does BCC a affect dark skinned races?

A

BCC predominantly affects Caucasians and is very uncommon in dark-skinned races.

BCC is the most common cancer in Europe, Australia and the USA and is showing a worldwide increase in incidence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Risk factors for BCC

A

The most significant aetiological factors appear to be genetic predisposition and exposure to ultraviolet (UV) radiation.

The sun-exposed areas of the head and neck are the most commonly involved sites. Sun exposure in childhood may be especially important.

Increasing age, male sex, skin types I and II (skin that always burns and never/only sometimes tans), immunosuppression and arsenic exposure are other recognised risk factors. A high dietary fat intake may also be relevant.

People diagnosed with one BCC are at increased risk of developing further BCCs. The risk of developing a second BCC within three years of the first presentation is approximately 44%.

Gorlin’s syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is Gorlin’s syndrome?

A

Gorlin’s Syndrome is a genetic condition resulting in the mutation of the Tumour Suppressor Gene PTCH 1.

It results in the development of multiple early onset BCCs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

How does Gorlin’s syndrome present?

A
Gorlin’s syndrome: This is also called naevoid BCC syndrome and It presents with: 
Autosomal dominant inheritance.
Multiple BCCs.
Pitting of the palms and soles.
Jaw cysts.
Spine and rib anomalies.
Calcification of the falx cerebri.
Cataracts.
Usually treated with imiquimod cream, chemotherapy and photodynamic therapy.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Presentation of BCC

A

The sun-exposed areas of the head and neck are the most commonly involved sites. Approximately 80% occur on the head and neck, with the rest mainly on the trunk and lower limbs.

Early lesions are often small, translucent or pearly and have raised areas with telangiectasia.

The classic rodent ulcer has an indurated edge and ulcerated centre. It is slow-growing but can spread deeply to cause considerable destruction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is nodular BCC?

A

Solitary, shiny, red nodule with large telangiectatic vessels.

Commonly on the face.

Cystic, pearly, telangiectasia.

May be ulcerated.

Micronodular and microcystic types may infiltrate deeply.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is superficial BCC?

A

Often multiple, usually on the upper trunk and shoulders.

Equal distribution over the face, trunk and limbs, although the site of predilection seems to vary according to sex (the head in women, the trunk in men).

Erythematous well-demarcated scaly plaques, often larger than 20 mm at presentation. Central clearing and a thread-like border. A rolled edge can be seen if stretched. The lesion may bleed or weep.

Slow growth over months or years; usually not aggressive, rarely become invasive and extremely rarely metastasise. Less likely to erode and ulcerate than nodular BCCs.

May be confused with Bowen’s disease or inflammatory dermatoses.

Particularly responsive to medical rather than surgical treatment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is morphoeic BCC?

A

Also known as sclerosing or infiltrative BCC.

Usually found in mid-facial sites.

More aggressive and have poorly defined borders.
Characterised by thickened yellowish plaques.

Often present late and may become very large and then require extensive plastic surgical reconstruction. May infiltrate cutaneous nerves (perineural spread).

Prone to recurrence after treatment.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is pigmented BCC?

A

Brown, blue or greyish lesion.
Nodular or superficial histology.
Seen more often in individuals with dark skin.
May resemble malignant melanoma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is basosquamous BCC?

A

Mixed BCC and SCC

Potentially more aggressive than other forms of BCC.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is periocular BCC?

A

This is a usually slow developing, usually painless and non-resolving lesion.

The most usual form and location is a small hard whitish nodule that appears on the lower eyelid.

Periocular BCC can also present in the medial canthus, upper lid, and lateral canthus.

It can present as nodular (hard nodule, pearly appearance, abnormal [telangiectatic] vessels), nodulo-ulcerative (as nodular but with raised rolled border surrounding central ulcer, may bleed), or morphoeic or sclerosing (flat hardened plaque of thickened skin, without surface vascularisation, ill-defined border making it difficult to determine area of involvement).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Differentials for nodular BCC

A

Intradermal naevus

Sebaceous hyperplasia

Fibrous papule

Molluscum contagiosum

Keratoacanthoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Differentials for superficial BCC

A
Discoid eczema 
Psoriasis 
Actinic keratosis 
Lichen simplex 
Bowen’s disease 
SCC 
Seborrhoeic wart
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Referral of BCC to secondary care

A

• NICE recommends:
Consider routine referral for people if they have a skin lesion that raises the suspicion of a BCC.

Only consider a suspected cancer pathway referral (for an appointment within two weeks) for people with a skin lesion that raises the suspicion of a BCC if there is particular concern that a delay may have a significant impact, because of factors such as lesion site or size.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Investigations for BCC

A

Investigation is primarily by visual inspection and removal for histology where necessary.

All excised specimens should be sent for histopathological examination.

When non-surgical treatments are used, an incisional biopsy must be sent before treatment for confirmation of the diagnosis.

Biopsy is also indicated when clinical doubt exists or when the histological subtype of BCC may influence treatment selection and prognosis.

17
Q

Is staging of BCC required?

A

For most patients with non-melanoma skin cancer (NMSC) no formal staging beyond clinical examination for lymphadenopathy is required.

CT or MRI scan is indicated in cases where bony involvement is suspected or where the tumour may have invaded major nerves, the orbit or the parotid gland.

18
Q

Management of low risk BCCs

A

NICE recommends that low-risk BCCs be managed in primary care as long as the GP meets the requirements to perform skin surgery within the framework of the Direct Enhanced Services and Local Enhanced Services.

There should be no diagnostic uncertainty that the lesion is a primary nodular low-risk BCC and meets the criteria.

  • Patient is not aged 24 years or younger, is immunosuppressed or has Gorlin’s syndrome.
  • The lesion is located below the clavicle and is less than 1 cm and is not a recurrent BCC nor persistent.
19
Q

Management of BCC

A

Surgery
Curettage and cautery
Cryotherapy
Non-surgical options such as imiquimod cream, fluorouracil cream, PDT, radiotherapy

20
Q

Surgery in the management of BCC

A

Excision with primary closure, flaps and grafts: an excision margin of 4 mm around the tumour is recommended where possible, especially for all high-risk BCCs.

Tumours which have been incompletely excised, especially high-risk BCC and lesions incompletely excised at the deep margin are at high risk of recurrence and should be re-excised.

21
Q

What is Mohs’ micrographic surgery?

A

Excision of the BCC is carried out in stages and each stage checked histologically.

It is advocated for use in cases where it is critical to obtain a clear margin while preserving the maximum amount of normal surrounding tissue, especially for recurrent and high-risk aggressive growth pattern BCCs such as morphoeic BCCs.

High-risk and recurrent tumours are best treated by Mohs’ micrographic surgery where this is available

22
Q

Curettage and cautery in the treatment of BCC

A

Not recommended for recurrent, large, morphoeic tumours or tumours on the face.

The overall cure rate is over 90% for low-risk BCCs.

Performed using a curette to remove soft material from the tumour.

The base of the tumour is then destroyed, using either hyfrecation or cautery.

Curettage and cautery is a good treatment for low-risk BCC

23
Q

What is imiquimod cream?

A

Imiquimod 5% cream:
Is an immune response-modifying agent that has been licensed for the treatment of small superficial BCCs.

Imiquimod has been shown to achieve clearance rates ranging from 70% to 100% but relapse rates appear higher than with other, conventional treatments and there are some difficulties with side-effects (eg, pruritus)

24
Q

PDT in the treatment of BCC

A

Effective for superficial and nodular BCC.

Involves the use of light therapy in combination with a topical photosensitising agent to destroy cancer cells.

Advantages of PDT include a low rate of adverse effects and a good cosmetic outcome.

The disadvantages are that the patient has to be available for a period of at least 3-4 hours for treatment, and that the photosensitiser and equipment are relatively expensive.

25
Q

Radiotherapy in the treatment of BCC

A

The best indications for radiotherapy are BCC with incomplete excision, recurrent BCC, nodular BCC of the head and neck under 2 cm and BCC with invasion of bone or cartilage.

Useful treatment for patients with NMSC who cannot be, or prefer not to be, treated by surgery.

The cure rates are over 90% for most skin lesions but the long-term cosmetic outcome, especially for young patients, is worse than for other treatments.

The same area cannot be treated twice and so surgery is required for any recurrence.

Radiotherapy can also be used in cases when the margins of excision appear to be incomplete on histopathological examination.

It should not be used to treat patients with Gorlin’s syndrome because of the carcinogenic potential of low-dose irradiation at the margins of the treated areas.

26
Q

Prevention of BCC

A

• Education on sun avoidance:
Avoid UV exposure in susceptible individuals, particularly children and adolescents.
Stay out of the sun between 10 am and 4 pm.
Use high-factor sunscreens.
Wear wide-brimmed hats, long-sleeved shirts and trousers.

  • Education of patients to seek early assessment if further lesions develop. Earlier treatment is more effective.
  • Oral retinoid treatment may prevent or delay the development of new BCCs